Zymar Eye Drops
PDF Leaflet Revision Date: 21 April 2023
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of bacterial conjunctivitis.
Dosage (summary)
Days 1-2: 1 drop every 2 hours (up to 8 times daily). Days 3-7: 1 drop up to 4 times daily.
Special Populations
- Paediatric use not established
- Geriatric use shows no differences
Pregnancy & Breastfeeding
Not recommended during pregnancy; unknown if excreted in breast milk.
Key Drug Interactions
- May elevate theophylline levels
- Interferes with caffeine metabolism
- Enhances warfarin effects
Contraindications
- Hypersensitivity to gatifloxacin or quinolones
Common side effects
- Conjunctivitis
- Punctate keratitis
- Increased lacrimation
- Eye irritation
- Headache
Counselling Points
- Do not wear contact lenses during treatment
- Avoid contact with the eye tip
- Wait 15 mins before reinserting contact lenses
Serious warnings
- Not suitable for injection
- Risk of serious hypersensitivity reactions
- Prolonged use may cause superinfection
Important Disclaimer
The Zymar Eye Drops professional information leaflet below is the property of AbbVie and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
